title: Maintenance treatment in metastatic colorectal cancer - Authors' reply.
authors.affiliation: Hope, Practice of Oncology, Hamburg, 20249, Germany. Electronic address: hegewisch@t-online.de.
authors.forename: Susanna
authors.initials: S
authors.lastname: Hegewisch-Becker
authors.affiliation: Kliniken Maria-Hilf GmbH, Department of Hematology, Oncology and Gastroenterology, Mönchengladbach, Germany.
authors.forename: Ullrich
authors.initials: U
authors.lastname: Graeven
authors.affiliation: Klinik für Tumorbiologie, Freiburg, Germany.
authors.forename: Dirk
authors.initials: D
authors.lastname: Arnold
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use*; D000069287:Capecitabine / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use*; D060046:Maintenance Chemotherapy; D008297:Male; D009944:Organoplatinum Compounds / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D009944:Organoplatinum Compounds; D000068258:Bevacizumab; D000069287:Capecitabine; D002955:Leucovorin; D005472:Fluorouracil